We are pleased to announce that the CA of JA3 WP4 on “Repetitive transcranial magnetic stimulation for treatment-resistant major depression” is available.
The purpose of the assessment is to examine the effectiveness and safety of repetitive transcranial magnetic stimulation (rTMS) in adult patients with treatment-resistant major depression. The analysis included CE-marked rTMS devices.
Final version of the assessment was published in April 2017.
Below is the documentation provided by the authoring team: